HJBC
- Following in the footsteps of Johnson & Johnson (JNJ) and Eli Lilly (LLY), Sanofi (NASDAQ:SNY) has become the latest pharma challenging HHS’ 340B program that provides discounted drugs to hospitals and clinics that primarily serve poor and underinsured patients.
- Although